AFM-19

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameAFM-19
Drug Alias Nameanti-chemokine antibody (Affimed)AFM-19
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody humanized
Mechanisms of ActionChemokine receptors antagonists
TargetsChemokine receptors
Therapy Area/IndicationsHypersensitivityPulmonary Disease, Chronic ObstructiveAsthma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermany
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAffimed Nv
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAffimed Nv
Active IndicationsN/A
Inactive IndicationsHypersensitivityPulmonary Disease, Chronic ObstructiveAsthma

Other Information

ATC CodeN/A
Related LinksN/A